Miltefosine comment watch save
BreastfeedingPediatric

  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    None known

Contraindicated in patients with Sjogren-Larsson-Syndrome.

EMBRYO-FETAL TOXICITY

See full prescribing information for complete boxed warning.

Please login to view the rest of this drug profile.

Page last updated 09/28/2024

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top